Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai, discusses how neurologic symptoms in individuals with HIV can present in various places in the body while also possibly pointing to a neurologic condition.
Some neurologic symptoms in patients with HIV can be more obvious than others, says Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai.
Transcript
What are some symptoms you look for in patients with HIV who you may suspect have a neurological complication of their HIV?
That can be really broad, and some of the symptoms, I think, are more overt than others. So, for example, in patients who have advanced immunosuppression and AIDS and we're worried about an infection in the brain, some of the symptoms might be things like headache or confusion [or] seizures. If it's an infection, you could have fever and other kinds of systemic signs of infection.
If it is a patient who is not particularly immunosuppressed, and has been doing well, often those neurologic complications are similar to somebody who didn't have HIV. In that case, you’re just basically starting with the symptoms that the patient complains of. Some of the things that I see a lot of are peripheral neuropathies. Those patients will sometimes complain of pain or numbness or tingling in the bottoms of their feet or coming up their legs. That can be a common symptom.
One of the other disorders that we see a lot of are HIV-associated neurocognitive disorders, which is abbreviated HAND, and those patients may report difficulty with different cognitive processes. So, maybe they're having trouble focusing like they used to, or handling their finances or their appointments or managing in their day-to-day life.
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More